- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Blue chip stocks
Global Pharmaceuticals & Biotech Blue chip stocks
Results
32
1 new
32 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ILMN | US$136.69 | 0.5% | -1.0% | US$22.2b | US$162.52 | PS4.9x | E56.7% | 2.3% | ||
GALD | CHF 108.50 | 6.4% | n/a | CHF 25.8b | CHF 101.70 | PS6.5x | E36.4% | n/a | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | ||
HZNP | US$116.30 | 0.06% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a | ||
UCB | €195.10 | 2.2% | 131.5% | €37.0b | €192.69 | PE154.2x | E28.4% | 0.7% | ||
TECH | US$73.31 | -0.7% | 1.6% | US$11.9b | US$85.26 | PE77.3x | E21.1% | 0.4% | ||
ARGX | €644.00 | 5.1% | 86.2% | €38.9b | €609.81 | PS20.9x | E43.5% | n/a | ||
ONC | US$176.71 | -2.3% | 0.9% | US$18.9b | US$280.92 | PS5.9x | E58.7% | n/a | ||
VRTX | US$409.56 | 0.6% | -5.5% | US$106.1b | US$492.97 | PS9.9x | E36.8% | n/a | ||
ALNY | US$237.98 | 1.6% | 23.1% | US$31.0b | US$298.97 | PS14.7x | E56.4% | n/a | ||
QGEN New | US$44.68 | -0.6% | -3.5% | US$10.1b | US$51.14 | PE106.9x | E34.4% | 2.9% | ||
VTRS | US$11.67 | -5.0% | -0.09% | US$14.3b | US$13.45 | PS0.9x | E51.6% | 4.1% | ||
SRPT | US$124.79 | -1.2% | 6.8% | US$12.1b | US$184.91 | PE97.8x | E31.9% | n/a | ||
EXAS | US$56.50 | -1.3% | -15.8% | US$10.5b | US$72.33 | PS3.9x | E58.4% | n/a | ||
A196170 | ₩309,500.00 | -2.8% | 226.5% | ₩16.5t | ₩565,000.00 | PS221.8x | E140.6% | n/a | ||
LLY | US$799.90 | 2.3% | 24.4% | US$708.8b | US$984.05 | PE86.1x | E25.0% | 0.8% | ||
GSK | UK£13.50 | 0.7% | -14.2% | UK£55.1b | UK£18.17 | PE21.9x | E20.4% | 4.3% | ||
ABBV | US$175.17 | -3.3% | 7.9% | US$315.4b | US$202.33 | PE60.9x | E22.8% | 3.7% | ||
A068270 | ₩185,100.00 | 2.3% | -1.3% | ₩40.1t | ₩237,426.30 | PE214.1x | E73.6% | 0.4% | ||
BMRN | US$67.38 | 0.8% | -27.8% | US$13.0b | US$97.66 | PE39.8x | E24.1% | n/a | ||
MEDP | US$350.87 | 3.4% | 22.4% | US$11.0b | US$347.92 | PE29.8x | E10.9% | n/a | ||
AZN | UK£109.82 | 3.7% | 1.1% | UK£170.3b | UK£144.08 | PE32x | E16.8% | 2.1% | ||
BMY | US$55.83 | -1.3% | 11.0% | US$115.2b | US$61.01 | PS2.4x | E38.4% | 4.4% | ||
INCY | US$70.54 | 1.3% | 12.4% | US$14.1b | US$79.42 | PE418.4x | E34.1% | n/a |